Zu "1207360-89-1" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
GDC-0349
Artikelnummer: LKT-G1310.1
GDC-0349 is an ATP-competitive inhibitor of mTOR that exhibits anticancer chemotherpeutic activity. GDC-0349 displays pre-clinical efficacy in vitro and in vivo.
| Schlagworte: | GDC0349 |
| Anwendung: | mTOR inhibitor |
| CAS | 1207360-89-1 |
| MW: | 452.55 D |
ab 209,00 €
GDC-0349
Artikelnummer: TGM-T6510-100mg
Description: GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kalpha and other 266 kinases. Phase 1. Target: Autophagy, mTOR, PI3K. Smiles: CCNC(=O)Nc1ccc(cc1)-c1nc2CN(CCc2c(n1)N1CCOC[C@@H]1C)C1COC1. References: Zhonghua Pei, et...
| Schlagworte: | RG-7603 |
| Anwendung: | mTOR inhibitor |
| CAS | 1207360-89-1 |
| MW: | 452.55 D |
ab 32,00 €
GDC-0349
Artikelnummer: Cay24058-1
GDC-0349 is a potent inhibitor of the mammalian target of rapamycin (mTOR, Ki = 3.8 nM). It is selective for mTOR over a panel of 266 kinases at a concentration of 1 µM. GDC-0349 inhibits proliferation of PC3 prostate cancer cells in vitro (EC50 = 270 nM) and induces caspase-dependent apoptosis in head and neck...
| Schlagworte: | N-ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]-urea |
| Anwendung: | mTOR inhibitor |
| CAS | 1207360-89-1 |
| MW: | 452.6 D |
ab 50,00 €
